3052 ORCHARD DRIVE, SAN JOSE, CA
Outset Medical Enters $40 Million Refresh Amendment with HCA
Annual Meeting Results: Election of Class III Directors Brent Lang & Karen Pr...
Executive Departure - Marc Nash Leaves Outset Medical, Inc.
Reports First-Quarter Results
Reports Fourth Quarter and Full Year 2025 Financial Results
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Investor Presentation
Financial Results, Press Release
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report